Metraipolis › archive › dc_d252f706aa64

Clinical Outcomes with the Use of Dipeptidyl Peptidase-4 (DPP-4) Inhibitor Among Patients with Diabetes Mellitus and COVID-19: A Systematic Review of… — Europe PMC PMID:41899041

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41899041
DOI
10.3390/jcm15062117
License (as archived)
solo-consultazione
Archived
2026-11-04T20:50:45.474Z
SHA-256 of the archived text
6feb41e5838f7a7e04daca3e58a65d52fd6ea6a9acd2c2aaf0d68391a7d14178
Stable URL of this page
https://metraipolis.com/documento/dc_d252f706aa64

How to cite

Clinical Outcomes with the Use of Dipeptidyl Peptidase-4 (DPP-4) Inhibitor Among Patients with Diabetes Mellitus and COVID-19: A Systematic Review of… — Europe PMC PMID:41899041 — Europe PMC (en), https://europepmc.org/article/MED/41899041 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d252f706aa64 (Metraipolis archive dc_d252f706aa64, sha256 6feb41e5838f7a7e04daca3e58a65d52fd6ea6a9acd2c2aaf0d68391a7d14178)
BibTeX
@misc{dcd252f706aa64,
  title = {Clinical Outcomes with the Use of Dipeptidyl Peptidase-4 (DPP-4) Inhibitor Among Patients with Diabetes Mellitus and COVID-19: A Systematic Review of… — Europe PMC PMID:41899041},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41899041},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d252f706aa64; sha256 6feb41e5838f7a7e04daca3e58a65d52fd6ea6a9acd2c2aaf0d68391a7d14178},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41899041. Agents can read the archived copy with the MCP tool read_document.